
|Videos|April 22, 2021
Impact of Initial Therapy on Front Line Maintenance Treatment Choice in Advanced Ovarian Cancer
Author(s)Rebecca Previs, MD
An expert in ovarian cancer describes how initial first line therapy impacts first line maintenance options.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves RP1/Nivolumab for Progression on Anti–PD-1 Therapy in Melanoma
2
The Lowest-Ever Hazard Ratio in Multiple Myeloma Bispecific Trials?
3
Developers Initiate Phase 2/3 Ivonescimab/EV Trial in Bladder Cancer
4
Why Earlier CAR T-Cell Therapy May Benefit Patients With Multiple Myeloma
5






























































